The expression of MBNL2 in HCC showed a heterogeneous distribution ranging from diffuse positive (>50%) in 21 cases (14.7%), heterogeneous positive (11-50%) in 30 cases (21.0%; Figure 1C), to positive in few tumor cells (≤10%) in 33 cases (23.1%; Figure 1D). This evidence concerns the gene MBNL2 and neoplasm.